Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Pharma & Drugs
Share your love
Common Eye Conditions – Names of Eye Diseases List
In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…
Novo Nordisk Weight Loss Drugs Linked to Higher NAION Risk
A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…
Fenofibrate Reduces Diabetic Retinopathy Risk by 27%
In a groundbreaking development for diabetes management, the LENS trial has revealed that fenofibrate, a medication typically used to lower cholesterol, can significantly reduce the risk of diabetic retinopathy progression by 27%. These findings were presented at the American Diabetes…
Mediwhale Secures $12M for AI Retina Diagnostics
Mediwhale, an AI-driven diagnostics company, has successfully raised $12 million in Series A2 funding to further develop its retina scanning technology aimed at diagnosing cardiovascular and metabolic diseases. This round was led by the Korea Development Bank, with contributions from…
Pine Pharmaceuticals Announces Recalls, Including Avastin
In response to a recent inspection by the U.S. FDA, Pine Pharmaceuticals has issued two voluntary recalls, including repackaged Avastin and other ocular use products. The company emphasizes that there have been no reported adverse events associated with the impacted…
World’s First Corneal Esthesiometer Approved by the FDA
Brill Engines, a subsidiary of Brill Pharma, specializing in pioneering medical solutions for ophthalmology, announced the FDA approval of its groundbreaking medical device, the Corneal Esthesiometer Brill (CEB). This approval marks a significant milestone in the field of ophthalmology, as…
FDA Warns Regener-Eyes Over Unapproved Amniotic Eye Drops
The FDA has issued a warning letter to the Regenerative Processing Plant, manufacturer of Regener-Eyes Pro and Lite eye drops, for marketing unapproved products claiming to treat dry eyes. These products, which contain amniotic fluid, raise significant safety concerns. The…
MCG Secures $1.5M Grant for New Diabetic Retinopathy Therapy
Researchers at the Medical College of Georgia (MCG) at Augusta University have been awarded a $1.5 million grant from the National Eye Institute to develop a new treatment for diabetic retinopathy, a leading cause of blindness. Diabetic retinopathy results from…
Dangers of Eye Color-Changing Drops: Ophthalmologists Warn
The American Academy of Ophthalmology is warning the public about over-the-counter eye drops that claim to change eye color. These products, popularized on social media platforms like TikTok, are unproven, unregulated, and could pose significant risks to eye health. Unapproved…
Opus Genetics Receives FDA RPD Designation for OPGx-LCA5
Research Triangle Park, N.C. – August 20, 2024 – Opus Genetics has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for its ocular gene therapy, OPGx-LCA5, which aims to treat patients with…